Clot Management Devices Market to be dominated by Neurovascular Embolectomy Devices through 2028
Increasing cardiovascular diseases is expected to drive
Global Clot Management Devices Market during the forecast period, 2024-2028.
According to TechSci Research report, “Clot Management Devices Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2018-2028”,
the global clot management devices market
is anticipated to grow at an impressive rate during the forecast period, 2024-2028.
This can be ascribed to the increasing coronary heart disease, periphery
arterial diseases, stroke and venous thromboembolism is further expected to
increase the demand for clot management devices. Similarly, increasing geriatric
population, increasing demand for effective thrombectomy or embolectomy devices
and increasing awareness regarding newer approaches for clot management device,
and growing awareness of using clot management device amongst the patient and
healthcare professionals across the world is expected to drive global clot
management devices market during the forecast period.
However, reimbursement
procedures are not well defined in many developing countries which may restrain
the growth of the global clot management devices market during the forecast
period. Additionally, high cost of clot management devices and availability of
alternative treatments are expected to hamper the overall market growth.
Browse over XX market data Figures
spread through XX
Pages and an in-depth TOC on "Clot Management Devices Market"
The global clot management devices market is segmented on the basis of product type,
end user, and region.
Based on product type, the global clot
management devices market can be fragmented into neurovascular embolectomy devices, embolectomy balloon
catheters, percutaneous thrombectomy devices, catheter directed thrombolysis
devices, and others. Neurovascular embolectomy
device type is expected to dominate the market during the forecast period,
owing to factors such as increasing investment in the research and development,
rising demand for cost effective devices and improvement in patient health
outcomes.
Based on region, the global clot management
devices market can be further divided into North America, Asia Pacific, Europe,
South America and Middle East & Africa. North America region is expected to
dominate the market in 2022 and maintain its dominance throughout the forecast
period. However, increasing prevalence of brain and heart strokes. Increasing
prevalence of cardiovascular and neurological diseases will support the market
growth in the forecast period.
Based on end user, the global clot management
device market can be further split into hospitals & clinics, ambulatory care centers, and others. Diagnostic centers are expected to dominate
the market during the forecast period. Increasing demand for reducing hospital
expenses and reduce waiting time for low-risk clot removal are the main factors
driving the global clot management devices market during the forecast period.
Major companies operating in global clot management devices market are:
- Medtronic Plc.
- Concentric Medical, Inc.
- Boston Scientific Corporation
- Edward LifeSciences
Corporation
- AngioDynamics, Inc.
- LeMaitre Vascular, Inc.
- Teleflex Incorporated
- Johnson & Johnson
- Strub Medical GmbH & Co.
KG
- Cook Group Incorporated
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“Asia Pacific is expected to register the highest growth in the global clot
management devices market on account increasing obesity, diabetes, and cardiovascular
disease due to change in lifestyle, increase in disposable income in countries such
as China and India. Similarly, increasing prevalence of targeted diseases
coupled with improvement in healthcare infrastructure and development of
technologically advanced products is further expected to support the market
growth. Additionally, a huge number of individuals are suffering from heart
ailments, Deep Vein Thrombosis and Pulmonary Embolism, which is expected to
drive market growth during the forecast period,” said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based global management
consulting firm.
“Clot
Management Devices Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2018-2028 Segmented By Product Type (Neurovascular Embolectomy Devices,
Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter
Directed Thrombolysis Devices, Others), By End User (Hospitals
& Clinics, Ambulatory Care Centers, Others), By Region and
Competition”, has evaluated
the future growth potential of global clot management devices market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global clot management devices market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com